Interactions of Aspergillus fumigatus with endothelial cells: Internalization, injury, and stimulation of tissue factor activity

Blood

Volumn 103, Issue 6, 2004, Pages 2143-2149

  Lopes Bezerra, Leila M ^b   Filler, Scott G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; THROMBOPLASTIN;

ANTIGEN EXPRESSION; ARTICLE; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; CELL DAMAGE; CONIDIUM; CONTROLLED STUDY; ENDOCYTOSIS; ENDOTHELIUM CELL; FUNGUS HYPHAE; HUMAN; HUMAN CELL; MICROFILAMENT; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; THROMBOSIS;

EID: 1542313905     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-06-2186     Document Type: Article

References (40)

1. Denning DW. Invasive aspergillosis. Clin Infect Dis. 1998;26:781-803; quiz 804-785.
2. Latge JP. Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev. 1999;12:310-350.
3. Bodey GP, Vartivarian S. Aspergillosis. Eur J Clin Microbiol Infect Dis. 1989;8:413-437.
4. Fraser RS. Pulmonary aspergillosis: pathologic and pathogenetic features. Pathol Annu. 1993; 28(pt 1):231-277.
5. Barth PJ, Rossberg C, Koch S, Ramaswamy A. Pulmonary aspergillosis in an unselected autopsy series. Pathol Res Pract. 2000;196:73-80.
6. Maruyama I. Biology of endothelium. Lupus. 1998;7(suppl 2):S41-S43.
7. Morrissey JH. Tissue factor: an enzyme cofactor and a true receptor. Thromb Haemost. 2001;86: 66-74.
8. Vallet B, Wiel E. Endothelial cell dysfunction and coagulation. Crit Care Med. 2001;29:S36-S41.
9. Doshi SN, Marmur JD. Evolving role of tissue factor and its pathway inhibitor. Crit Care Med. 2002; 30:S241-S250.
10. Combes V, Simon AC, Grau GE, et al. In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. J Clin Invest. 1999;104:93-102.
11. Mallat Z, Benamer H, Hugel B, et al. Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation. 2000;101:841-843.
12. Deighton FJ, Hall NK, Larsh HW. Merthiolate treatment of pathogenic fungi. J Clin Microbiol. 1979;10:144-146.
13. Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins: identification by morphologic and immunologic criteria. J Clin Invest. 1973;52:2745-2756.
14. Belanger PH, Johnston D, Fratti RA, Zhang M, Filler SG. Endocytosis of Candida albicans by vascular endothelial cells is associated with tyrosine phosphorylation of specific host cell proteins. Cell Microbiol. 2002;4:805-812.
15. Fhan QT, Belanger PH, Filler SG. Role of hyphal formation in interactions of Candida albicans with endothelial cells. Infect Immun. 2000;68:3485-3490.
16. Fratti RA, Ghannoum MA, Edwards JE Jr, Filler SG. Gamma interferon protects endothelial cells from damage by Candida albicans by inhibiting endothelial cell phagocytosis. Infect Immun. 1996;64:4714-4718.
17. Tsuchimori N, Sharkey LL, Fonzi WA, French SW, Edwards JE Jr, Filler SG. Reduced virulence of HWP1-deficient mutants of Candida albicans and their interactions with host cells. Infect Immun. 2000;68:1997-2002.
18. Levitz SM, DiBenedetto DJ, Diamond RD. A rapid fluorescent assay to distinguish attached from phagocytized yeast particles. J Immunol Meth. 1987;101:37-42.
19. Filler SG, Swerdloff JN, Hobbs C, Luckett PM. Penetration and damage of endothelial cells by Candida albicans. Infect Immun. 1995;63:976-983.
20. Filler SG, Ibe BO, Luckett PM, Raj JU, Edwards JE Jr. Candida albicans stimulates endothelial cell eicosanoid production. J Infect Dis. 1991;164: 928-935.
21. Bancsi MJ, Thompson J, Bertina RM. Stimulation of monocyte tissue factor expression in an in vitro model of bacterial endocarditis. Infect Immun. 1994;62:5669-5672.
22. Ibrahim AS, Filler SG, Alcouloumre MS, Kozel TR, Edwards JE Jr, Ghannoum MA. Adherence to and damage of endothelial cells by Cryptococcus neoformans in vitro: role of the capsule. Infect Immun. 1995;63:4368-4374.
23. Hayashi H, Takagi R, Onda M, Kumazaki T. Invasive pulmonary aspergillosis occluding the descending aorta and left pulmonary artery: CT features. J Comput Assist Tomogr. 1994;18:492-494.
24. Denning DW, Ward PN, Fenelon LE, Benbow EW. Lack of vessel wall elastolysis in human invasive pulmonary aspergillosis. Infect Immun. 1992;60:5153-5156.
25. Wasylnka JA, Moore MM. Uptake of Aspergillus fumigatus conidia by phagocytic and nonphagocytic cells in vitro: quantitation using strains expressing green fluorescent protein. Infect Immun. 2002;70:3156-3163.
26. Paris S, Boisvieux-Ulrich E, Crestani B, et al. Internalization of Aspergillus fumigatus conidia by epithelial and endothelial cells. Infect Immun. 1997;65:1510-1514.
27. Kunert J, Kopecek P. Multiple forms of the serine protease Alp of Aspergillus fumigatus. Mycoses. 2000;43:339-347.
28. Birch M, Robson G, Law D, Denning DW. Evidence of multiple extracellular phospholipase activities of Aspergillus fumigatus. Infect Immun. 1996;64:751-755.
29. Filler SG, Pfunder AS, Spellberg BJ, Spellberg JP, Edwards JE Jr. Candida albicans stimulates cytokine production and leukocyte adhesion molecule expression by endothelial cells. Infect Immun. 1996;64:2609-2617.
30. Filler SG, Ibe BO, Ibrahim AS, Ghannoum MA, Raj JU, Edwards JE Jr. Mechanisms by which Candida albicans induces endothelial cell prostaglandin synthesis. Infect Immun. 1994;62:1064-1069.
31. Orozco AS, Zhou X, Filler SG. Mechanisms of the pro-inflammatory response of endothelial cells to Candida albicans infection. Infect Immun. 2000; 68:1134-1141.
32. Cannom RRM, French SW, Johnston D, Edwards JE Jr, Filler SG. Candida albicans stimulates local expression of leukocyte adhesion molecules and cytokines in vivo. J Infect Dis. 2002;186:389-396.
33. Parker JC Jr, McCloskey JJ, Knauer KA. Pathobiologic features of human candidiasis: a common deep mycosis of the brain, heart and kidney in the altered host. Am J Clin Pathol. 1976;65: 991-1000.
34. Drake TA, Pang M. Staphylococcus aureus induces tissue factor expression in cultured human cardiac valve endothelium. J Infect Dis. 1988; 157:749-756.
35. Veltrop MH, Beekhuizen H, Thompson J. Bacterial species- and strain-dependent induction of tissue factor in human vascular endothelial cells. Infect Immun. 1999;67:6130-6138.
36. Heyderman RS, Klein NJ, Daramola OA, et al. Induction of human endothelial tissue factor expression by Neisseria meningitidis: the influence of bacterial killing and adherence to the endothelium. Microb Pathog. 1997;22:265-274.
37. Osterud B, Bjorklid E. The tissue factor pathway in disseminated intravascular coagulation. Semin Thromb Hemost. 2001;27:605-617.
38. Bouwman JJ, Visseren FL, Bosch MC, Bouter KP, Diepersloot RJ. Procoagulant and inflammatory response of virus-infected monocytes. Eur J Clin Invest. 2002;32:759-766.
39. Bea F, Puolakkainen MH, McMillen T, et al. Chlamydia pneumoniae induces tissue factor expression in mouse macrophages via activation of Egr-1 and the MEK-ERK1/2 pathway. Circ Res. 2003;92:394-401.
40. Veltrop MH, Thompson J, Beekhuizen H. Monocytes augment bacterial species- and strain-dependent induction of tissue factor activity in bacterium-infected human vascular endothelial cells. Infect Immun. 2001;69:2797-2807.